日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Midkine (MDK) as a central regulator of the tumor microenvironment: From developmental cytokine to therapeutic target

中肾素(MDK)作为肿瘤微环境的核心调控因子:从发育细胞因子到治疗靶点

Nair, Hareesh B; Nair, Ajay; Liu, Ya-Guang; Vijayan, Dileep K; Subramani, Ramadevi; Lakshmanaswamy, Rajkumar; Viswanadhapalli, Suryavathi; Sareddy, Gangadhara R; Batra, Surinder K; Vadlamudi, Ratna K

Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer.

LIPA靶向治疗的优化,以诱导卵巢癌内质网应激和细胞死亡。

Viswanadhapalli Suryavathi, Lee Tae-Kyung, Elmore Scott, Sharma Gaurav, Gopalam Rahul, Panneerdoss Durga Meenakshi, Liu Xihui, Parra Karla, Reese Tanner, Hsieh Michael, Pratap Uday P, Yang Xue, Ebrahimi Behnam, Li Xiaonan, Neal Henry, Chen Chia-Yuan, Kassees Kara, Cervantes Christian, Baker Adriana, Subbarayalu Panneerdoss, Ramirez Paulina, Lyons Yasmin A, Lai Zhao, Chen Yidong, Boerma Joseph W, LoCoco Peter M, Clanton Nicholas A, Xu Zhenming, Rao Manjeet, Rao Tekmal Rajeshwar, Kost Edward, Sareddy Gangadhara R, Raj Ganesh V, Ahn Jung-Mo, Vadlamudi Ratna K

Ligand-receptor interactions induce and mediate regulatory functions of BATF3(+) B cells.

配体-受体相互作用诱导和介导 BATF3(+) B 细胞的调节功能。

Yan Hui, Wang Rui, Viswanadhapalli Suryavathi, Cervantes Christian, He Funan, Wu Shuai, Khosh Azad, Luo Weiwei, Wang Jingwei, Fernandez Maria J, Pratap Uday P, Khan Mustafa, Hinton Karli, Vankamamidi Sai Eashan, Perez Dariela, Rivera Carlos E, Gupta Harshita B, Zhang Fushun, Ye Zhenqing, Chen Yidong, Li Xiao-Dong, Sareddy Gangadhara R, Zan Hong, Li Yue, Wang Exing, Bunnik Evelien M, Zhong Guangming, Hunter Christopher A, Kedl Ross M, Yin Zhinan, Min Booki, Ebrahimi Diako, Zheng Siyuan, Curiel Tyler J, Xiang Yan, Vadlamudi Ratna K, Casali Paolo, Xu Zhenming

The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

发现并鉴定出新型中肾素抑制剂HBS-101,作为治疗三阴性乳腺癌的治疗药物

Mahajan, Megharani; Rodriguez Sanchez, Alondra L; Jayamohan, Sridharan; Vijayan, Dileep K; Johnson, Jessica D; Xie, Huan; Wang, Yang; Liang, Dong; Sanchez, John R 2nd; Subbarayalu, Panneerdoss; Rao, Manjeet K; Vadlamudi, Ratna K; Sareddy, Gangadhara R; Nair, Hareesh B; Viswanadhapalli, Suryavathi

Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma

赖氨酸特异性去甲基化酶 1 和激酶信号通路的联合抑制作为胶质母细胞瘤的临床前治疗策略

Stitzlein, Lea M; Nam, Deokhwa; Hernandez, Faith A; Patel, Kareena H; Poche, Alaina; Ma, Huaxian; Impelman, Katie; Gumin, Joy; Wang, Heping; Wang, Jing; Gadd, Samantha; Zaky, Wafik; Becher, Oren; Dudley, Richard W; Lang, Frederick F; Sareddy, Gangadhara R; Chandra, Joya

PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide

PRMT5抑制剂可增强胶质母细胞瘤肿瘤模型对替莫唑胺的敏感性

Onishi, Shumpei; Jayamohan, Sridharan; Chowdhury, Ashis; Rivas, Sarah; Otani, Yoshihiro; Murphy, Sara A; Rivera-Caraballo, Kimberly A; Walbridge, Stuart; Shah, Ashish H; Sisay, Bayu; Maric, Dragan; Elkahloun, Abdel; Johnson, Kory; Heiss, John; Lee, Tae Jin; Kumbar, Sangamesh G; Brown, Desmond A; Yoo, Ji Young; Brenner, Andrew; Kaur, Balveen; Sareddy, Gangadhara R; Banasavadi-Siddegowda, Yeshavanth Kumar

Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress

作者更正:靶向 LIPA(而非其脂肪酶活性)是通过诱导内质网应激治疗实体瘤的一种策略。

Liu, Xihui; Viswanadhapalli, Suryavathi; Kumar, Shourya; Lee, Tae-Kyung; Moore, Andrew; Ma, Shihong; Chen, Liping; Hsieh, Michael; Li, Mengxing; Sareddy, Gangadhara R; Parra, Karla; Blatt, Eliot B; Reese, Tanner C; Zhao, Yuting; Chang, Annabel; Yan, Hui; Xu, Zhenming; Pratap, Uday P; Liu, Zexuan; Roggero, Carlos M; Tan, Zhenqiu; Weintraub, Susan T; Peng, Yan; Tekmal, Rajeshwar R; Arteaga, Carlos L; Lippincott-Schwartz, Jennifer; Vadlamudi, Ratna K; Ahn, Jung-Mo; Raj, Ganesh V

KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.

KDM1A/LSD1抑制剂可增强卵巢癌的化疗反应

Chen Yihong, Johnson Jessica D, Jayamohan Sridharan, He Yi, Venkata Prabhakar P, Jamwal Diksha, Alejo Salvador, Zou Yi, Lai Zhao, Viswanadhapalli Suryavathi, Vadlamudi Ratna K, Kost Edward, Sareddy Gangadhara R

Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma

赖氨酸特异性组蛋白去甲基化酶1A (KDM1A/LSD1) 抑制剂可减弱DNA双链断裂修复,并增强替莫唑胺在胶质母细胞瘤中的疗效。

Alejo, Salvador; Palacios, Bridgitte E; Venkata, Prabhakar Pitta; He, Yi; Li, Wenjing; Johnson, Jessica D; Chen, Yihong; Jayamohan, Sridharan; Pratap, Uday P; Clarke, Kyra; Zou, Yi; Lv, Yingli; Weldon, Korri; Viswanadhapalli, Suryavathi; Lai, Zhao; Ye, Zhenqing; Chen, Yidong; Gilbert, Andrea R; Suzuki, Takayoshi; Tekmal, Rajeshwar R; Zhao, Weixing; Zheng, Siyuan; Vadlamudi, Ratna K; Brenner, Andrew J; Sareddy, Gangadhara R

Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study

赖氨酸特异性去甲基化酶 1 作为癌症治疗靶点:来自临床前研究的观察

Johnson, Jessica D; Alejo, Salvador; Jayamohan, Sridharan; Sareddy, Gangadhara R